short communications under five broad headings: clinical studies,
translational therapeutics, molecular diagnostics, genetics and
genomics, and epidemiology. BJC also commissions a very successful
series of minireviews on highly topical subjects.
Click here to read two free sample issues online:
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0EN50EF
British Journal of Cancer
27 May 2008, Volume 98, Issue 11
Table of Contents
Editorial
1729 The screening mammography paradox: better when found, perhaps
better not to find
D A Berry
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMR0Ed
_____________________________________________________________________
Reviews
1731 Circulating endothelial cells in oncology: pitfalls and promises
M H Strijbos, J W Gratama, J Kraan, C H Lamers, MA den Bakker & S
Sleijfer
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMS0Ee
1736 Risks and benefits of bisphosphonates
R E Coleman
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMS0Ee
_____________________________________________________________________
Clinical Studies
1741 Screen-detected vs symptomatic breast cancer: is improved
survival due to stage migration alone?
G C Wishart, D C Greenberg, P D Britton, P Chou, C H Brown, A D
Purushotham & S W Duffy
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMT0Ef
_____________________________________________________________________
1745 Factors that predict early treatment failure for patients with
locally advanced (T4) breast cancer
E Montagna, V Bagnardi, N Rotmensz, J Rodriguez, P Veronesi, A
Luini, M Intra, E Scarano, A Cardillo,
R Torrisi, G Viale, A Goldhirsch & M Colleoni
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMU0Eg
_____________________________________________________________________
1753 Changes of bone turnover markers and serum PTH after night or
morning administration of zoledronic acid in breast cancer patients
with bone metastases
D Generali, A Dovio, M Tampellini, M Tucci, S Tedoldi, M Torta, S
Bonardi, G Allevi,
S Aguggini, M Milani, A L Harris, A Bottini, L Dogliotti, A
Angeli & A Berruti
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMV0Eh
_____________________________________________________________________
1759 Radiographer gender and breast-screening uptake
P Fitzpatrick, A Winston & T Mooney
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMW0Ei
_____________________________________________________________________
1762 A pharmaco-economic analysis of second-line treatment with
imatinib or sunitinib in patients with advanced gastrointestinal
stromal tumours
I Contreras-Hernández, J F Mould-Quevedo, A Silva, G
Salinas-Escudero, M A Villasís-Keever,
V Granados-García, G Dávila-Loaiza, J A Petersen & J
Garduño-Espinosa
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMX0Ej
_____________________________________________________________________
1769 Enhancing treatment decision-making: pilot study of a treatment
decision aid in stage IV non-small cell lung cancer
N B Leighl, F A Shepherd, D Zawisza, R L Burkes, R Feld, J
Waldron, A Sun,
D Payne, A Bezjak & M H N Tattersall
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMY0Ek
_____________________________________________________________________
1774 A phase Ib trial of docetaxel, carboplatin and erlotinib in
ovarian, fallopian tube and primary peritoneal cancers
P A Vasey, M Gore, R Wilson, G Rustin, H Gabra, J-P Guastalla, E
P Lauraine, J Paul,
K Carty & S Kaye on behalf of the Scottish Gynaecological Cancer
Trials Group
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMZ0El
_____________________________________________________________________
1781 Inverse association of NSAID use and ovarian cancer in relation
to oral contraceptive use and parity
K J Wernli, P A Newcomb, J M Hampton, A Trentham-Dietz & K M Egan
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMa0Es
_____________________________________________________________________
Translational Therapeutics
_____________________________________________________________________
1784 Characterisation of tumour vasculature in mouse brain by USPIO
contrast-enhanced MRI
G Gambarota, W Leenders, C Maass, P Wesseling, B van der Kogel,
O van Tellingen & A Heerschap
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMb0Et
_____________________________________________________________________
1790 Knocking down gene expression for growth hormone-releasing
hormone inhibits proliferation of human cancer cell lines
N Barabutis & A V Schally
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMc0Eu
_____________________________________________________________________
1797 Differential effects of ketoconazole on exposure to temsirolimus
following intravenous infusion of temsirolimus
J P Boni, C Leister, J Burns & B Hug
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMd0Ev
_____________________________________________________________________
1803 Cisplatin alters nitric oxide synthase levels in human ovarian
cancer cells: involvement in p53 regulation and cisplatin resistance
E L Leung, M Fraser, R R Fiscus & B K Tsang
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMe0Ew
_____________________________________________________________________
1810 SPARC promoter hypermethylation in colorectal cancers can be
reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and
improve therapy response
S Cheetham, M J Tang, F Mesak, H Kennecke, D Owen & I T Tai
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMf0Ex
_____________________________________________________________________
Molecular Diagnostics
_____________________________________________________________________
1820 MMP-2 geno-phenotype is prognostic for colorectal cancer
survival, whereas MMP-9 is not
A M J Langers, C F M Sier, L J A C Hawinkels, F J G M Kubben, W
van Duijn, J J van der Reijden, C B H W Lamers,
D W Hommes & H W Verspaget
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMg0Ey
_____________________________________________________________________
1824 Mitotic centromere-associated kinesin is a novel marker for
prognosis and lymph node metastasis in colorectal cancer
K Ishikawa, Y Kamohara, F Tanaka, N Haraguchi, K Mimori, H Inoue
& M Mori
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMh0Ez
_____________________________________________________________________
1830 Prognostic molecular markers with no impact on decision-making:
the paradox of gliomas based on a prospective study
M Wager, P Menei, J Guilhot, P Levillain, S Michalak, B Bataille,
J-L Blanc, F Lapierre,
P Rigoard, S Milin, F Duthe, D Bonneau, C-J Larsen & L
Karayan-Tapon
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMi0E1
_____________________________________________________________________
1839 Mitochondria-dependent signalling pathway are involved in the
early process of radiation-induced bystander effects
S Chen, Y Zhao, W Han, G Zhao, L Zhu, J Wang, L Bao, E Jiang, A
Xu, T K Hei, Z Yu & L Wu
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMj0E2
_____________________________________________________________________
1845 Aberrant CDKN1A transcriptional response associates with abnormal
sensitivity to radiation treatment
C Badie, S Dziwura, C Raffy, T Tsigani, G Alsbeih, J Moody, P
Finnon, E Levine, D Scott & S Bouffler
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMk0E3
_____________________________________________________________________
Epidemiology
_____________________________________________________________________
1852 Diagnostic radiation procedures and risk of prostate cancer
P Myles, S Evans, A Lophatananon, P Dimitropoulou, D Easton, T
Key, R Pocock, D Dearnaley,
M Guy, S Edwards, L O'Brien, B Gehr-Swain, A Hall, R Wilkinson, R
Eeles & K Muir
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMl0E4
_____________________________________________________________________
1857 Opium, tobacco, and alcohol use in relation to oesophageal
squamous cell carcinoma in a high-risk area of Iran
D Nasrollahzadeh, F Kamangar, K Aghcheli, M Sotoudeh, F Islami,
C C Abnet, R Shakeri,
A Pourshams, H A Marjani, M Nouraie, M Khatibian, S Semnani, W
Ye, P Boffetta, S M Dawsey & R Malekzadeh
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMm0E5
_____________________________________________________________________
1864 Association of physical activity with cancer incidence,
mortality, and survival: a population-based study of men
N Orsini, C S Mantzoros & A Wolk
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMm0E5
____________________________________________________________________
1870 Incidence of interstitial pneumonitis among breast cancer
patients: a 10-year Danish population-based cohort study
S Christensen, L Pedersen, M Grijota, J B Kornum, A Beiderbeck &
H T Sørensen
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMn0E6
____________________________________________________________________
1876 Lower breast cancer survival in mothers of children with a
malignancy: a national study
H Olsson, S Magnusson & A Bladström
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMn0E6
____________________________________________________________________
Letter to the Editor
____________________________________________________________________
1879 Japanese mobile phone study
B Hocking
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMn0E6
____________________________________________________________________
Corrigendum
____________________________________________________________________
1880 The E3 ubiquitin ligase EDD is an adverse prognostic factor for
serous epithelial ovarian cancer and modulates cisplatin resistance in
vitro
P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J
Henderson, D N Saunders,
B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R
Murali, R A Scolyer,
Y Zeng, E D Williams, L Scurr, A DeFazio, Di Quinn, C K W Watts,
N F Hacker, S M Henshall & R L Sutherland
http://ealerts.nature.com/cgi-bin24/DM/y/elAf0Xztnp0Hhi0BwMo0E7
____________________________________________________________________
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
